Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy. Issue 2 (25th November 2022)

• Record Type: Journal Article
• Authors: Mastrangelo, Andrea; Mammana, Angela; Baiardi, Simone; Tiple, Dorina; Colaizzo, Elisa; Rossi, Marcello; Vaianella, Luana; Polischi, Barbara; Equestre, Michele; Poleggi, Anna; Capellari, Sabina; Ladogana, Anna; Parchi, Piero
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 94:Issue 2(2023)
• Page Start: 121
• Page End: 129
• Publication Date: 2022-11-25
• Subjects: CREUTZFELDT-JAKOB DISEASE -- PRION -- CSF -- DEMENTIA -- NEUROPATHOLOGY; Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp-2022-330153
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : Background: The introduction of the prion Real-Time Quaking-Induced Conversion assay (RT-QuIC) has led to a revision of the diagnostic criteria for sporadic Creutzfeldt-Jakob disease (sCJD). Validation studies are needed for the amended criteria, especially for their diagnostic value in the clinical setting. Methods: We studied 1250 patients with suspected CJD referred for diagnosis to two Italian reference centres between 2010 and 2020. Focusing on the first diagnostic assessment, we compared the diagnostic value of the old and the amended criteria and that of different combinations of clinical variables and biomarker results. Results: The studied cohort comprised 850 participants with CJD (297 definite sCJD, 151 genetic CJD, 402 probable sCJD) and 400 with non-CJD (61 with neuropathology). At first clinical evaluation, the sensitivity of the old criteria (76.8%) was significantly lower than that of the amended criteria (97.8%) in the definite CJD cohort with no difference between definite and probable sCJD cases. Specificity was ~94% for both criteria against the non-CJD cohort (82.0% against definite non-CJD group). Cerebrospinal fluid (CSF) RT-QuIC was highly sensitive (93.9%) and fully specific against definite non-CJD patients. Limiting the criteria to a positive RT-QuIC or/and the combination of a clinical course compatible with possible CJD with a positive MRI (Q-CM criteria) provided higher diagnostic accuracy than both the old and amended criteria, overcoming the suboptimal specificity of ancillary test results (ie, CSF protein 14-3-3). Conclusions: CSF RT-QuIC is highly sensitive and specific for diagnosing CJD in vitam. The Q-CM criteria provide a high diagnostic value for CJD.